Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018681 (
headache
)
56,091
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several clinical trials suggest that botulinum toxin type-A (BTX-A) may be an effective treatment option for patients with chronic tension-type
headache
(CTTH); however, controversy remains as to how the botulinum toxin optimally should be used for treating
headache
and which patient's profile fits this treatment. The objective of this study was to evaluate the efficacy and tolerability of BTX-A for the prophylactic treatment of
CCTH
in Egyptian patients. This was a randomized, single-blind, placebo-controlled study of BTX-A for the treatment of patients aged 25-50 years old with
CCTH
. Following a 30-day screening,
headache
parameters and severity assessed by the standard visual analogue scale (VAS), and the 25-item Henry Ford Hospital
Headache
Disability Inventory (HDI) were recorded as a baseline. Then, injection was done with either BTX-A or with saline by a combination of two methods for detecting injection sites (the fixed-site approach and follow-the-pain approach). Our study showed significant improvement after 1 month of BTX-A injection regarding
headache
days/month, severity measured by VAS and HDI in
headache
severity. There was significant reduction of prophylactic medications, and there were minor complications, but these reversed spontaneously without further treatment. BTX-A was an effective and well-tolerated prophylactic treatment in Egyptian patients with
CCTH
.
J
Headache
Pain 2009 Feb
PMID:Botulinum toxin: could it be an effective treatment for chronic tension-type headache? 1903 Sep 47
Chronic tension-type headache (CTTH) is the most common type of
headache
with no truly effective treatment. This study was designed to correlate the additive effect of meditation on CTTH patients receiving medical treatment. 50 patients (aged 18-58 years) presenting with a clinical diagnosis of
CCTH
, were divided in 2 groups. Group 1 (n=30) received 8 lessons and practical demonstration of Brahmakumaris spiritual based meditation known as Rajyoga meditation for relaxation therapy, in addition to routine medical treatment (analgesics and muscle relaxants). Group 2 (n=20) patients received analgesics and muscle relaxants twice a day but no relaxation therapy in the form of meditation. Both groups were followed up for 8 weeks period. The parameters studied were severity, frequency and duration of
CCTH
, and their
headache
index calculated. Patients in both groups showed a highly significant reduction in
headache
variables (P<0.001) after 8 weeks. But the percentage of patients showing highly significant relief in severity of
headache
, duration & frequency in Group 1 was 94%, 91% and 97% respectively whereas in Group 2 it was 36%, 36% and 49% respectively.
Headache
relief as calculated by
headache
index was 99% in Group 1 as compared to 51% in Group 2. Even Short term spiritual based relaxation therapy (Rajyoga meditation) was highly effective in causing earlier relief in chronic tension headache as measured by
headache
parameter.
...
PMID:Effect of rajyoga meditation on chronic tension headache. 2550 67